Shiranee Sriskandan

SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses

Wanwisa Dejnirattisai, Jiandong Huo, Daming Zhou et al. · Cell · 2022 · 1K citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study

Clark D Russell, Cameron J Fairfield, Thomas M Drake et al. · The Lancet Microbe · 2021 · 334 citations · Full text

Pharmacy, Infectious Disease Control, Infectious Diseases +17

Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19

Ryan S. Thwaites, Ashley Sanchez Sevilla Uruchurtu, Matthew K. Siggins et al. · Science Immunology · 2021 · 259 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Emergence of dominant toxigenic M1T1 Streptococcus pyogenes clone during increased scarlet fever activity in England: a population-based molecular epidemiological study

Nicola N. Lynskey, Elita Jauneikaite, Ho Kwong Li et al. · The Lancet Infectious Diseases · 2019 · 248 citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +13

Specific C‐Terminal Cleavage and Inactivation of Interleukin‐8 by Invasive Disease Isolates of <i>Streptococcus pyogenes</i>

Robert J. Edwards, Graham W. Taylor, Melissa Ferguson et al. · The Journal of Infectious Diseases · 2005 · 203 citations · Full text

Veterinary Medicine, Immunology, Microbiology +17